These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7403123)

  • 1. Reassessment of the anticonvulsant activity of alpha, alpha-diphenyl-succinimide.
    Jones MF; Jones GL; Amato RJ; Peyton GA; Wimbish GH
    Proc West Pharmacol Soc; 1980; 23():171-4. PubMed ID: 7403123
    [No Abstract]   [Full Text] [Related]  

  • 2. [Anticovulsant activity of N-(p-sulfamoyl-phenyl)-succinimide derivatives (author's transl)].
    Waser PG; Ganz AJ; Pfirrmann RW
    Arzneimittelforschung; 1977; 27(10):1942-53. PubMed ID: 579105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the anticonvulsant, neurotoxic and lethal effects of diphenylbarbituric acid, phenobarbital and diphenylhydantoin in the mouse.
    Raines A; Niner JM; Pace DG
    J Pharmacol Exp Ther; 1973 Aug; 186(2):315-22. PubMed ID: 4719784
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacologic interactions of albutoin with other anticonvulsant drugs.
    Wallin RF; Blackburn WH; Napoli MD
    J Pharmacol Exp Ther; 1970 Aug; 174(2):276-82. PubMed ID: 5451364
    [No Abstract]   [Full Text] [Related]  

  • 5. Antiepileptic drug combinations and experimental background: the case of phenobarbital and phenytoin.
    Bourgeois BF
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Aug; 333(4):406-11. PubMed ID: 3774019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticonvulsant activity of delta9-tetrahydrocannabilol and its 11-hydroxy and 8alpha, 11-dihydroxy metabolites in the frog.
    Karler R; Cely W; Turkanis SA
    Res Commun Chem Pathol Pharmacol; 1974 Nov; 9(3):441-52. PubMed ID: 4548551
    [No Abstract]   [Full Text] [Related]  

  • 7. Anticonvulsant properties of some new derivatives of phensuccinimide.
    Rump S; Ilczuk I; Walczyna K
    Arzneimittelforschung; 1979; 29(2):290-2. PubMed ID: 582142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modification of the antiepileptic actions of phenobarbital and phenytoin by the taurine transport inhibitor, guanidinoethane sulfonate.
    Izumi K; Kishita C; Nakagawa K; Huxtable RJ; Shimizu T; Koja T; Fukuda T
    Eur J Pharmacol; 1985 Apr; 110(2):219-24. PubMed ID: 3987813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticonvulsant action of new cyclic derivatives of phenylsuccinimides.
    Chmielewska B
    Pharmazie; 1983 Dec; 38(12):872-3. PubMed ID: 6669617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-(anilinomethyl)-p-isopropoxyphenylsuccinimide potentiates the anticonvulsant action of phenobarbital and valproate in the mouse maximal electroshock-induced seizure model.
    Luszczki JJ; Kocharov SL; Czuczwar SJ
    Neurosci Res; 2009 Jul; 64(3):267-72. PubMed ID: 19447295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. alpha,alpha-Diphenylsuccinimide: evaluation of anticonvulsant and hydrophobic properties.
    Jones GL; Amato RJ; Jones MF
    J Pharm Sci; 1984 Mar; 73(3):310-3. PubMed ID: 6716236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and properties of cyclic derivatives of succinic acid with anticonvulsant activity. Part 3.
    Lange J; Rump S; Ilczuk I; Lapszewicz J; Rabsztyn T; Walczyna K
    Pharmazie; 1979 Dec; 34(12):794-5. PubMed ID: 545347
    [No Abstract]   [Full Text] [Related]  

  • 13. Imperatorin enhances the protective activity of conventional antiepileptic drugs against maximal electroshock-induced seizures in mice.
    Luszczki JJ; Glowniak K; Czuczwar SJ
    Eur J Pharmacol; 2007 Nov; 574(2-3):133-9. PubMed ID: 17651727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2-phosphonomethyl-pentanedioic acid (glutamate carboxypeptidase II inhibitor) increases threshold for electroconvulsions and enhances the antiseizure action of valproate against maximal electroshock-induced seizures in mice.
    Luszczki JJ; Mohamed M; Czuczwar SJ
    Eur J Pharmacol; 2006 Feb; 531(1-3):66-73. PubMed ID: 16403497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p-Aminobenzene sulphonyl morpholine, compound 82/208 a new anticonvulsant agent.
    Dua PR; Ahuja P; Anand N
    Indian J Exp Biol; 1994 Oct; 32(10):729-31. PubMed ID: 7821984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticonvulsant activity of reaction products of 5,5-diphenylhydantoin with substituted methylene bromides.
    Usifoh CO
    Arch Pharm (Weinheim); 2001 Nov; 334(11):366-8. PubMed ID: 11822175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and anticonvulsant activity of racemic 2-amino-N-substituted succinimide derivatives.
    Crider AM; Kolczynski TM; Miskell DL
    J Pharm Sci; 1981 Feb; 70(2):192-5. PubMed ID: 7205225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of antiepileptic drugs on brain energy reserves during convulsions.
    King LJ; Carl J
    J Neurochem; 1969 Apr; 16(4):637-43. PubMed ID: 5768218
    [No Abstract]   [Full Text] [Related]  

  • 19. Anticonvulsant pharmacokinetics.
    Breckenridge A
    Proc R Soc Med; 1974 Jan; 67(1):63-4. PubMed ID: 4595345
    [No Abstract]   [Full Text] [Related]  

  • 20. A quantitative structure-activity relationship (QSAR) analysis of the effects of aromatic substitution on the anticonvulsant activity and toxicity of arylsuccinimides.
    Lange J; Kaźmierski W; Daroszewski J
    Pol J Pharmacol Pharm; 1991; 43(1):71-7. PubMed ID: 1771166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.